Gene therapy continues to mature and to face challenges.
作者信息
Williams David A
出版信息
Mol Ther. 2009 Aug;17(8):1305-6. doi: 10.1038/mt.2009.162.
Abstract
摘要
相似文献
1
Gene therapy continues to mature and to face challenges.基因治疗在持续发展成熟的同时也面临着挑战。
Mol Ther. 2009 Aug;17(8):1305-6. doi: 10.1038/mt.2009.162.
2
New hopes for gene therapy.基因治疗的新希望。
Curr Biol. 2014 Oct 20;24(20):R983-6. doi: 10.1016/j.cub.2014.10.003.
3
Development challenges associated with rAAV-based gene therapies.腺相关病毒（AAV）载体基因治疗相关的开发挑战。
J Toxicol Sci. 2021;46(2):57-68. doi: 10.2131/jts.46.57.
4
Gene therapy revisited. In spite of problems and drawbacks, gene therapy moves forward.基因治疗再探讨。尽管存在问题和缺陷，但基因治疗仍在向前发展。
EMBO Rep. 2001 Dec;2(12):1064-5. doi: 10.1093/embo-reports/kve260.
5
The current status of clinical gene therapy.临床基因治疗的现状。
Hum Gene Ther. 2002 Jul 20;13(11):1261-2. doi: 10.1089/104303402760128496.
6
Hematopoietic stem cell gene therapy: progress on the clinical front.造血干细胞基因治疗：临床前沿进展
Hum Gene Ther. 2014 Mar;25(3):165-70. doi: 10.1089/hum.2014.2504. Epub 2014 Feb 28.
7
What next for human gene therapy? Gene transfer often has multiple and unpredictable effects on cells.人类基因治疗的下一步是什么？基因转移通常会对细胞产生多种不可预测的影响。
BMJ. 2003 Jun 28;326(7404):1410-1. doi: 10.1136/bmj.326.7404.1410.
8
Current status of CF gene therapy.囊性纤维化基因治疗的现状。
Trends Genet. 1996 Mar;12(3):81-4. doi: 10.1016/0168-9525(96)81410-7.
9
In Utero Gene Therapy Consensus Statement from the IFeTIS.国际胎儿治疗与干预学会（IFeTIS）的宫内基因治疗共识声明。
Mol Ther. 2019 Apr 10;27(4):705-707. doi: 10.1016/j.ymthe.2019.02.015. Epub 2019 Mar 2.
10
Five years of vector service for gene therapy.用于基因治疗的五年载体服务。
Trends Genet. 2002 Mar;18(3):118-9. doi: 10.1016/s0168-9525(01)02603-8.
引用本文的文献
1
Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice.胰岛素基因工程化的支持细胞可降低糖尿病小鼠的血糖
DNA Cell Biol. 2018 Aug;37(8):680-690. doi: 10.1089/dna.2017.3937. Epub 2018 Jun 21.
2
Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c mice.基因工程改造的支持细胞系在糖尿病BALB/c小鼠同种异体移植后持续表达胰岛素。
Biol Reprod. 2014 May;90(5):109. doi: 10.1095/biolreprod.113.115600. Epub 2014 Apr 2.
3
Ectopic platelet-delivered factor (F) VIII for the treatment of Hemophilia A: Plasma and platelet FVIII, is it all the same?异位血小板递送因子VIII治疗甲型血友病：血浆和血小板来源的VIII因子，是否完全相同？
J Genet Syndr Gene Ther. 2011 Nov 12;Suppl 1(1). doi: 10.4172/2157-7412.S1-001.
4
Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy.基因工程改造的免疫豁免支持细胞：基于细胞的基因治疗的新途径。
Spermatogenesis. 2012 Jan 1;2(1):23-31. doi: 10.4161/spmg.19119.
5
When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.当伦理限制临床研究时：“大于最小风险”儿科试验中对照臂的试验设计。
Hum Gene Ther. 2011 Sep;22(9):1121-7. doi: 10.1089/hum.2010.230. Epub 2011 May 19.
6
Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.鸡 HS4 绝缘子在转导 HIV1 为基础的慢病毒载体的人造血细胞的后代中具有最小的屏障功能。
Mol Ther. 2011 Jan;19(1):133-9. doi: 10.1038/mt.2010.218. Epub 2010 Oct 12.
7
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.在因重型地中海贫血或镰状细胞病而接受骨髓移植后长期、持续存在造血混合嵌合体的患者中，存在定量不同的红细胞/有核细胞嵌合体。
Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7.
8
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.通过基因转移纠正小儿患者造血祖细胞中的重型β地中海贫血。
EMBO Mol Med. 2010 Aug;2(8):315-28. doi: 10.1002/emmm.201000083.
9
Hybrid lentiviral vectors.混合慢病毒载体。
Mol Ther. 2010 Jul;18(7):1263-7. doi: 10.1038/mt.2010.76. Epub 2010 Apr 20.
本文引用的文献
1
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.经过基因工程改造以共表达肿瘤特异性受体的病毒特异性T细胞：在神经母细胞瘤患者中的持久性和抗肿瘤活性
Nat Med. 2008 Nov;14(11):1264-70. doi: 10.1038/nm.1882. Epub 2008 Nov 2.
Zotero 插件